Antiretroviral therapy (ART) has represented a major advancement in the care of people
living with HIV (PLWHH), resulting in significant reductions in morbidity and mortality through …

Chronic anemia is more prevalent in people living with HIV (PLWH) compared to the general
population. The mechanisms that drive chronic anemia in HIV are multifaceted and include …

Tuberculosis (TB) is associated with systemic inflammation and anemia, which are
aggravated in persons living with HIV (PLWH). Here, we characterized the dynamics of …

Background Tuberculosis (TB) is an infectious morbidity that commonly occurs in people
living with HIV (PWH) and increases the progression of HIV disease, as well as the risk of …

Background: Women progress to death at the same rate as men despite lower plasma HIV
RNA (viral load). We investigated sex-specific differences in immune activation and …

Background Accurate forecast of the death risk is crucial to the administration of people
living with HIV/AIDS (PLHIV). We aimed to establish and validate an effective prognosis …

Background To assess the prevalence of anemia before and after antiretroviral therapy
(ART) initiation and to identify impact of anemia on mortality among HIV-infected patients in …

Background After initiating antiretroviral therapy (ART), approximately 25% of people with
HIV (PWH) may develop Immune Reconstitution Inflammatory Syndrome (IRIS), which is …

Methods: We conducted a case-cohort study (n= 332) within a randomized trial comparing 3
ART regimens in 1571 HIV treatment-naive adults from 9 countries. A subcohort of 30 …

Background The C-reactive protein (CRP) response is often measured in patients with active
tuberculosis (TB) yet little is known about its relationship to clinical features in TB, or whether …